A8D-28129-06902
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 152 / PA
- Registered
- 2022-02-05
- Relationship
- Child or adolescent in my care
- Guardian
- 9GP-27266-99247
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-01-08
Dose 1 — Pfizer-BioNTech
-
2022-02-05
Registered in v-safe
- 2022-02-05
-
2022-02-12
Dose 2 — Pfizer-BioNTech
- 2022-02-19
- 2022-02-26
- 2022-03-05
-
2022-03-12
Survey response — day 28, dose 2, dependentMedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Has a cold. Covid negative by PCR.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-19
- 2022-03-26
- 2022-05-14
- 2022-08-13
- 2023-02-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-08 | Pfizer-BioNTech | No |
| 2 | 2022-02-12 | Pfizer-BioNTech | No |
Free text
Release 11 — day 28, dose 2, dependent
Symptoms: Has a cold. Covid negative by PCR.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release